Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;36(13):1811-1818.
doi: 10.1097/QAD.0000000000003348. Epub 2022 Aug 10.

Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era

Affiliations

Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era

Gabriel Spieler et al. AIDS. .

Abstract

Objective: To examine type 2 diabetes mellitus incidence and associated risk factors among people with HIV (PWH).

Design: A retrospective clinical cohort study of PWH at a Southeastern US academic HIV clinic between 2008 and 2018.

Methods: PWH who attended at least two clinic visits were evaluated with demographic and clinical data extracted from the electronic medical record (EMR). Diabetes was defined as: hemoglobin A1C ≥6.5% and/or 2 glucose results >200 mg/dl (at least 30 days apart), diagnosis of diabetes in the EMR, or exposure to diabetes medication. Time to diabetes incidence was computed from the entire clinic population for each year. Multivariable Cox proportional hazard regression models with time-dependent covariates were created to evaluate the independent association between covariates and time to incident diabetes.

Results: Among 4113 PWH, we identified 252 incident cases of diabetes. Incidence increased from 1.04 incidents per 1000 person years (PY) in 2008, to 1.55 incidents per 1000 PY in 2018. Body mass index (hazard ratio [HR] 10.5 (6.2, 17.7)), liver disease (HR 1.9 (1.2, 3.1)), steroid exposure (HR 1.5 (1.1, 1.9)), and use of integrase inhibitors (HR 1.5 (1.1, 2.0)) were associated with incident diabetes. Additional associated factors included lower CD4 + cell counts, duration of HIV infection, exposure to nonstatin lipid-lowering therapy, and dyslipidemia.

Conclusions: Rapidly increasing incident diabetes rates among PWH were associated with both traditional and HIV-related associated risk factors, particularly body weight, steroid exposure, and use of Integrase Inhibitors. Notably, several of the risk factors identified are modifiable and can be targeted for intervention.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:

There are no conflicts of interest.

Figures

Figure 1
Figure 1
a. Incident diabetes by year (2008–2018). b. Prevalent diabetes by year (2008–2018).
Figure 2.
Figure 2.
Multivariable analysis of factors associated with increased risk of diabetes diagnosis among people receiving care for HIV between 2008–2018. BMI, body mass index; IV, intravenous; MSM, men who have sex with men; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-nucleoside reverse transcriptase inhibitors; II, Integrase Inhibitors; CKD/ESRD, chronic kidney disease/end-stage renal disease; ESLD, end-stage liver disease

References

    1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013; 382(9903):1525–1533. - PMC - PubMed
    1. Willig AL, Overton ET. Metabolic consequences of HIV: pathogenic insights. Current HIV/AIDS reports 2014; 11(1):35–44. - PubMed
    1. Willig AL, Overton ET. Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence. Current HIV/AIDS reports 2016; 13(5):289–296. - PMC - PubMed
    1. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of internal medicine 2005; 165(10):1179–1184. - PubMed
    1. American Diabetes Association Professional Practice C, American Diabetes Association Professional Practice C, Draznin B, Aroda VR, Bakris G, Benson G, et al. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes care 2022; 45(Supplement_1):S39–S45. - PubMed

Publication types